NCT04505683View on ClinicalTrials.gov

A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

December 13, 2018

Primary Completion Date

May 8, 2020

Study Completion Date

May 8, 2020

Conditions

Complicated Urinary Tract Infection Including Acute Pyelonephritis

Interventions

DRUG

Benapenem

Benapenem for IV injection administered as a 1-gram IV infusion

DRUG

Ertapenem

Ertapenem for IV injection administered as a 1-gram IV infusion

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Sihuan Pharmaceutical Holdings Group Ltd.

INDUSTRY

NCT04505683 - A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) | Biotech Hunter | Biotech Hunter